Latest News for: theras

Edit

Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia

PR Newswire 27 Mar 2025
About Bio-Thera Solutions.Bio-Thera Solutions, Ltd., a leading innovative, global biopharmaceutical company in Guangzhou, China, is dedicated to researching and developing novel therapeutics for ...
Edit

Dr Reddy's inks South East Asia commercialisation, licence pacts with China's Bio-Thera for Stelara, Simponi biosimilars

The Times of India 26 Mar 2025
Dr Reddy’s Labs on Wednesday said its subsidiary, Dr Reddy’s Labs SA, has entered into commercialisation and licencing agreements with China’s Bio-Thera Solutions for biosimilars of two of Janssen’s ...
Edit

DRL Bio Thera press release 26.03.2025 final (Dr Reddy's Laboratories Limited)

Public Technologies 26 Mar 2025
Bio-Thera and Dr ... Guangzhou, China/ Hyderabad, India - March 26, 2025 - Bio-Thera Solutions (688177.SH; "Bio- Thera"), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Dr.
  • 1
×